XML 106 R85.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements and Derivative Instruments (Nonfinancial Instruments) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Total, impairment $ 562 $ 82,001 $ 1,566,380
Fair Value, Measurements, Nonrecurring      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Long-lived assets, impairment 10,186 [1] 55,213 [2]  
Total, impairment 10,186 [1] 55,213 [2]  
Fair Value, Measurements, Nonrecurring | Total Carrying Amount      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Long-lived assets 0 0  
Total 0 0  
Fair Value, Measurements, Nonrecurring | Total Fair Value      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Long-lived assets 0 0  
Total 0 0  
Fair Value, Measurements, Nonrecurring | Level 3      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]      
Long-lived assets 0 0  
Total $ 0 $ 0  
[1] Amount is primarily composed of construction in progress assets that were impaired during the year ended December 31, 2022 due to a reduction in scope or the decision to not complete the projects. The impairments were calculated based on orderly liquidation values. The fair value of these assets was estimated as of the date the assets were last impaired.
[2] Amount is primarily composed of construction in progress assets that were impaired during the year ended 2021 due to a reduction in scope or the decision to not complete the projects. The impairments were calculated based on orderly liquidation values. The fair value of these assets was estimated as of the date the assets were last impaired.